Accessibility Menu
Lantheus Stock Quote

Lantheus (NASDAQ: LNTH)

$57.26
(-0.8%)
-0.44
Price as of October 22, 2025, 1:08 p.m. ET

KEY DATA POINTS

Current Price
$57.26
Daily Change
(-0.8%) $0.44
Day's Range
$56.94 - $57.94
Previous Close
$57.7
Open
$57.5
Beta
0.89
Volume
17,913
Average Volume
1,738,898
Market Cap
3.9B
Market Cap / Employee
$57.70M
52wk Range
$47.25 - $118.21
Revenue
-
Gross Margin
0.64%
Dividend Yield
N/A
EPS
$3.76
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Lantheus Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
LNTH-48.52%+343.5%+34.7%+797%
S&P+15.06%+95.03%+14.29%+220%

Lantheus Company Info

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and Puerto Rico, third-party distribution in Europe, Canada, Australia, Asia-Pacific, and Latin America, and the EXINI business in Sweden. The company was founded in 1956 and is headquartered in Bedford, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$378.05M-4.1%
Gross Profit$241.01M-5.8%
Gross Margin63.75%-1.2%
Market Cap$5.66B1.8%
Market Cap / Employee$7.01M0.0%
Employees808-3.1%
Net Income$78.76M26.9%
EBITDA$101.20M-13.8%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$695.57M-8.1%
Accounts Receivable$336.58M-9.6%
Inventory62.2-11.9%

Liabilities

Q2 2025YOY Change
Long Term Debt$614.70M-0.4%
Short Term Debt$0.80M-73.1%

Ratios

Q2 2025YOY Change
Return On Assets13.36%-12.8%
Return On Invested Capital6.19%1.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$79.15M7.6%
Operating Free Cash Flow$87.11M2.8%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings18.2420.4627.7021.7465.41%
Price to Book6.595.376.364.86-18.93%
Price to Sales5.364.044.543.79-3.98%
Price to Tangible Book Value8.236.718.005.96-21.95%
Price to Free Cash Flow TTM17.7412.6214.8212.08-15.82%
Enterprise Value to EBITDA51.5446.6857.4856.0919.08%
Free Cash Flow Yield5.6%7.9%6.7%8.3%18.80%
Return on Equity45.5%32.8%24.1%24.7%-54.46%
Total Debt$621.30M$621.31M$614.40M$615.49M-0.77%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.